These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. Nassif A; Jia J; Keiser M; Oswald S; Modess C; Nagel S; Weitschies W; Hosten N; Siegmund W; Kühn JP Radiology; 2012 Sep; 264(3):741-50. PubMed ID: 22771883 [TBL] [Abstract][Full Text] [Related]
5. Proper definitions of MRI contrast enhancement in liver tumors. Ni Y; Chen F; Wang H; Feng Y; Li J; Jiang Y J Gastroenterol; 2010 Mar; 45(3):349-50; author reply 351-2. PubMed ID: 20012916 [No Abstract] [Full Text] [Related]
6. Polymorphisms in the organic anion transporting polypeptide genes influence liver parenchymal enhancement in gadoxetic acid-enhanced MRI. Okubo H; Ando H; Kokubu S; Miyazaki A; Watanabe S; Fujimura A Pharmacogenomics; 2013 Oct; 14(13):1573-82. PubMed ID: 24088128 [TBL] [Abstract][Full Text] [Related]
7. Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Leonhardt M; Keiser M; Oswald S; Kühn J; Jia J; Grube M; Kroemer HK; Siegmund W; Weitschies W Drug Metab Dispos; 2010 Jul; 38(7):1024-8. PubMed ID: 20406852 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. Kitao A; Zen Y; Matsui O; Gabata T; Kobayashi S; Koda W; Kozaka K; Yoneda N; Yamashita T; Kaneko S; Nakanuma Y Radiology; 2010 Sep; 256(3):817-26. PubMed ID: 20663969 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid. Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116 [TBL] [Abstract][Full Text] [Related]
10. Advanced fibrosis: Correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver. Lagadec M; Doblas S; Giraudeau C; Ronot M; Lambert SA; Fasseu M; Paradis V; Moreau R; Pastor CM; Vilgrain V; Daire JL; Van Beers BE Radiology; 2015 Feb; 274(2):379-86. PubMed ID: 25289480 [TBL] [Abstract][Full Text] [Related]
11. Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1). Niemi M; Kivistö KT; Hofmann U; Schwab M; Eichelbaum M; Fromm MF Br J Clin Pharmacol; 2005 May; 59(5):602-4. PubMed ID: 15842561 [No Abstract] [Full Text] [Related]
12. Liver-specific magnetic resonance contrast medium in the evaluation of chronic liver disease. Reis MA; Baroni RH Einstein (Sao Paulo); 2015; 13(2):326-9. PubMed ID: 26154554 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs. Ieiri I; Higuchi S; Sugiyama Y Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):703-29. PubMed ID: 19442037 [TBL] [Abstract][Full Text] [Related]
14. Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging. Tsuda N; Matsui O Radiology; 2010 Sep; 256(3):767-73. PubMed ID: 20663976 [TBL] [Abstract][Full Text] [Related]
15. Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. Yoneda N; Matsui O; Kitao A; Kozaka K; Kobayashi S; Sasaki M; Yoshida K; Inoue D; Minami T; Gabata T Radiographics; 2016; 36(7):2010-2027. PubMed ID: 27740898 [TBL] [Abstract][Full Text] [Related]
16. Peak enhancement of the femoral head. Sonmez G; Incedayi M; Sivrioglu AK AJR Am J Roentgenol; 2011 Oct; 197(4):W781; author reply W782. PubMed ID: 21940554 [No Abstract] [Full Text] [Related]
17. Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance. Sheng RF; Wang HQ; Yang L; Jin KP; Xie YH; Fu CX; Zeng MS Dig Liver Dis; 2017 Jul; 49(7):789-795. PubMed ID: 28237298 [TBL] [Abstract][Full Text] [Related]
18. Features of acute liver congestion on gadoxetate disodium-enhanced MRI in a rat model: Role of organic anion-transporting polypeptide 1A1. Shimizu A; Kobayashi A; Motoyama H; Sakai H; Yamada A; Yoshizawa A; Momose M; Kadoya M; Miyagawa S J Magn Reson Imaging; 2015 Sep; 42(3):828-36. PubMed ID: 25581836 [TBL] [Abstract][Full Text] [Related]